CCL18 expressed from TAMs plays a critical role in immune and inflammation responses, and its receptor CCR8 marks suppressive Treg cells within the tumor [48] suggesting the immunosuppressive potential of the CCL18-CCR8 axis in bone metastatic ccRCC. The gene discussed is CCL18; the disease is neoplasm.